People

  1. Lestrange
    Lestrange
  2. Klimstra
    Klimstra
  3. Li
    Li
  4. Stetson
    Stetson
  5. Roy
    Roy
  6. Shi
    Shi
  7. Ling
    Ling
  8. Middha
    Middha
  9. Levy
    Levy
  10. Van Der Ploeg
    Van Der Ploeg
  11. Burdziak
    Burdziak
  12. Thummar
    Thummar
  13. Pillarsetty
    Pillarsetty
  14. Park
    Park
  15. Hu
    Hu

Recent Works

  1. Patient-centered outcomes in ARIEL3, a phase 3, randomized, placebo-controlled study of rucaparib maintenance treatment in patients with recurrent ovarian carcinoma
    Meeting Abstract

    Bedel, D. J.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; Leary, A.; more...
    Value in Health (2019)

    Fulltext@MSK | Save
  2. Quality adjusted time without symptoms of disease progression or toxicity (Q-TWIST) of nivolumab plus ipilimumab (NIVO+IPI) vs sunitinib (SUN) among untreated advanced renal cell carcinoma (ARCC) patients (patients) with intermediate or poor prognostic risk
    Meeting Abstract

    Shah, R.; Botteman, M.; Kwon, Y.; Gooden, K. M.; Cella, D.; Motzer, R.
    Value in Health (2019)

    Fulltext@MSK | Save
  3. Cost-effectiveness of a 24-month fixed duration of venetoclax in combination with rituximab in relapsed or refractory chronic lymphocytic leukemia in the United States
    Meeting Abstract

    Huntington, S. F.; Strunz-McKendry, T.; Masaquel, A. S.; Shapouri, S.; Sail, K.; Durno, N.; Mato, A.
    Value in Health (2019)

    Fulltext@MSK | Save